Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension.

Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D, Sagan A, Wu J, Vinh A, Marvar PJ, Guzik B, Podolec J, Drummond G, Lob HE, Harrison DG, Guzik TJ.

FASEB J. 2016 May;30(5):1987-99. doi: 10.1096/fj.201500088R. Epub 2016 Feb 12.

2.

Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.

Chan CT, Moore JP, Budzyn K, Guida E, Diep H, Vinh A, Jones ES, Widdop RE, Armitage JA, Sakkal S, Ricardo SD, Sobey CG, Drummond GR.

Hypertension. 2012 Nov;60(5):1207-12. doi: 10.1161/HYPERTENSIONAHA.112.201251. Epub 2012 Oct 1.

PMID:
23033370
3.

A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium.

Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison DG, Giddens DP, Jo H.

J Vis Exp. 2010 Jun 22;(40). pii: 1861. doi: 10.3791/1861.

4.

Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more?

Budzyn K, Sobey CG, Drummond GR.

J Hypertens. 2010 Jul;28(7):1384-9. doi: 10.1097/HJH.0b013e32833c03fe. No abstract available.

PMID:
20574249
5.

Therapeutic targeting of mitochondrial superoxide in hypertension.

Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI.

Circ Res. 2010 Jul 9;107(1):106-16. doi: 10.1161/CIRCRESAHA.109.214601. Epub 2010 May 6.

6.

Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.

Miller AA, Budzyn K, Sobey CG.

Clin Sci (Lond). 2010 Apr 7;119(1):1-17. doi: 10.1042/CS20090649. Review.

PMID:
20370718
7.

Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis.

Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison D, Giddens D, Jo H.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1535-43. doi: 10.1152/ajpheart.00510.2009. Epub 2009 Aug 14.

8.

Mechanisms of augmented vasoconstriction induced by 5-hydroxytryptamine in aortic rings from spontaneously hypertensive rats.

Budzyn K, Ravi RM, Miller AA, Sobey CG.

Br J Pharmacol. 2008 Sep;155(2):210-6. doi: 10.1038/bjp.2008.247. Epub 2008 Jun 16.

9.

Vascular rho kinases and their potential therapeutic applications.

Budzyn K, Sobey CG.

Curr Opin Drug Discov Devel. 2007 Sep;10(5):590-6. Review.

PMID:
17786858
10.

Segmental differences in the roles of rho-kinase and protein kinase C in mediating vasoconstriction.

Budzyn K, Paull M, Marley PD, Sobey CG.

J Pharmacol Exp Ther. 2006 May;317(2):791-6. Epub 2006 Feb 1.

PMID:
16452393
11.

Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.

Budzyn K, Marley PD, Sobey CG.

Trends Pharmacol Sci. 2006 Feb;27(2):97-104. Epub 2005 Dec 27. Review.

PMID:
16376997
12.

Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.

Budzyn K, Marley PD, Sobey CG.

J Pharmacol Exp Ther. 2005 Jun;313(3):1248-53. Epub 2005 Mar 2.

PMID:
15743931
13.

Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.

Chrissobolis S, Budzyn K, Marley PD, Sobey CG.

Stroke. 2004 Sep;35(9):2200-5. Epub 2004 Jul 15.

PMID:
15256679
14.

Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice.

Budzyn K, Marley PD, Sobey CG.

Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R342-8. Epub 2004 May 6.

15.

A microscopic view of false tendons in the left ventricle of the human heart.

Lotkowski D, Grzybiak M, Kozłowski D, Budzyn K, Kuta W.

Folia Morphol (Warsz). 1997;56(1):31-9.

PMID:
9409077

Supplemental Content

Loading ...
Support Center